Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 8/20 | 0.55 |
| ▸ | MEN1 | O00255 | 7/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.54 |
| ▸ | NPC1 | O15118 | 9/20 | 0.50 |
| ▸ | RAB9A | P51151 | 9/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29986507 | 0.98 | AR (0.54) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL29986181 | 0.92 | AR (0.53) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL2408313 | 0.91 | MEN1 (0.51) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL30103590 | 0.91 | AR (0.51) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL16696486 | 0.87 | MEN1 (0.51) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL24662769 | 0.85 | MEN1 (0.49) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL10304851 | 0.85 | MEN1 (0.51) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL7918710 | 0.84 | CYP3A4 (0.53) | ARMEN1KMT2ANPC1RAB9A | |
| 2-Phenylquinoline SCHEMBL18107977 | 0.84 | RAB9A (0.54) | ARMEN1KMT2ANPC1RAB9A | |
| SCHEMBL17343420 | 0.84 | MEN1 (0.51) | ARMEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11404650-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-08-02 | — | — | US | claimed |
| EP-3691620-A1 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. (US) | 2020-08-12 | — | — | EP | claimed |
| WO-2019071147-A1 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. (US) | 2019-04-11 | — | — | WO | claimed |
| US-20160155958-A1 | BICYCLIC IRIDIUM COMPLEX AND PROCESS FOR PREPARING SAME, ORGANIC LIGHT EMITTING DEVICE AND PROCESS FOR PREPARING SAME | HEFEI BOE OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-06-02 | — | — | US | claimed |
| CN-103113413-B | Dicyclo complex of iridium and preparation method, organic electroluminescence device and preparation method | HEFEI BOE OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-03-02 | — | — | CN | claimed |
| CN-105121592-A | Prevention of sludge formation during acidizing procedures | ECOLAB USA INC | 2015-12-02 | — | — | CN | claimed |
| CN-103113413-A | Bicyclo-iridium complex, preparation method of complex, organic light emitting diode (OLED) and preparation method of OLED | HEFEI BOE OPTOELECTRONICS TECH | 2013-05-22 | — | — | CN | claimed |
| WO-2005010081-A1 | AROMATIC MONOMER-AND CONJUGATED POLYMER-METAL COMPLEXES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-03 | — | — | WO | claimed |
| US-20050014023-A1 | Aromatic monomer- and conjugated polymer-metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-01-20 | — | — | US | claimed |
| US-6358945-B1 | CYTOKINE, TUMOR NECROSIS FACTOR, AND INTERLEUKIN INHIBITORS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2002-03-19 | — | — | US | claimed |
| EP-0671454-B1 | Process for removal of heteroatoms | EXXON RESEARCH ENGINEERING CO (US) | 2000-09-06 | — | — | EP | claimed |
| US-5611915-A | Process for removal of heteroatoms under reducing conditions in supercritical water | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1997-03-18 | — | — | US | claimed |
| EP-0671454-A2 | Process for removal of heteroatoms | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1995-09-13 | — | — | EP | claimed |
| CN-115448876-B | Asymmetric transfer hydrogenation method for quinoline | 哈尔滨工业大学（深圳） | 2023-10-31 | — | — | CN | disclosed |
| CN-112250708-B | Anthracene-containing dimer skeleton ligand, preparation method thereof and application thereof in metal catalytic reaction | 中国科学院理化技术研究所 | 2023-10-13 | — | — | CN | disclosed |
| EP-4159212-A1 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| WO-1998050541-A1 | METHODS AND COMPOSITIONS TO FACILITATE D-LOOP FORMATION BY OLIGONUCLEOTIDES | EPOCH PHARMACEUTICALS, INC. (US) | 1998-11-12 | — | — | WO | disclosed |
| EP-0558481-B1 | COLOR CHANGING DEVICE FOR MONITORING SHELF-LIFE OF PERISHABLE PRODUCTS | JP LAB INC (US) | 1998-03-04 | — | — | EP | disclosed |
| EP-0558481-A1 | COLOR CHANGING DEVICE FOR MONITORING SHELF-LIFE OF PERISHABLE PRODUCTS | JP LABORATORIES, INC. (US) | 1993-09-08 | — | — | EP | disclosed |
| WO-1992009870-A1 | COLOR CHANGING DEVICE FOR MONITORING SHELF-LIFE OF PERISHABLE PRODUCTS | J.P. LABORATORIES, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11404650-B2 | Stability OLED materials and devices | OCIAD2, OCIAD1, OSBP2 | AR 1119/4885MEN1 3298/4885KMT2A 2787/4885 |
| US-20160155958-A1 | BICYCLIC IRIDIUM COMPLEX AND PROCESS FOR PREPARING SAME, ORGANIC LIGHT EMITTING DEVICE AND PROCESS FOR PREPARING SAME | ORC3, INO80C, INTS9 | AR 1773/4885MEN1 2655/4885KMT2A 1357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.